ENTITY
BGI Genomics

BGI Genomics (300676 CH)

36
Analysis
Health CareChina
BGI Genomics Co., Ltd offers researching and testing services. The Company provides deoxyribonucleic acid sequencing, food science, health care researching, cancer prevention, drug discovery, and DNA sequencing. BGI Genomics offers services to medical and scientific research institutions worldwide.
more
10 Sep 2024 14:39

The US Biosecure Act: A Boon for Indian CDMO Players?

​The Biosecure Act passed by the U.S. House could boost Indian CDMOs as alternative to Chinese biotechs by 2032, leading to potential growth...

Logo
516 Views
Share
18 Aug 2024 10:59

China Healthcare Weekly (Aug.18)- COVID Is Here, BIOSECURE Act Update, Livzon Deserves More Patience

COVID is coming again. So investors can focus on related stocks. US companies leaving Chinese partners due to BIOSECURE Act. Livzon is still worth...

Logo
284 Views
Share
19 Apr 2024 09:16
Smartkarma Originals

China Population Policies Impact on Healthcare Companies Series – Part 4

​Different provinces expand coverage for assisted reproductive services in medical insurance. Livzon missed expectation in 2023.US sanction on BGI...

Logo
2.3k Views
Share
05 Jan 2024 10:32
Smartkarma Originals

China Population Policies Impact on Healthcare Companies Series - Part 3

We updated the most recent changes in relevant fertility support policies in China. Meanwhile, we also analyzed our views on the performance and...

Logo
1k Views
Share
03 Oct 2023 09:19
Smartkarma Originals

China Population Policies Impact on Healthcare Companies Series – Part 2

Several regions have successively introduced policies to encourage childbirth, so we analyzed the recent policy updates. Based on Livzon/BGI...

Logo
856 Views
Share
x